Thirty years of experience with epicardial pacing in children

Nicolas Noiseux1, Paul Khairy, Anne Fournier

  • 1Department of Cardiovascular Surgery, Children's Hospital Boston, Harvard Medical School, USA.

Cardiology in the Young
|February 1, 2005
PubMed

Insights

Epicardial pacing is a reliable method for children, though reintervention is common within five years. Long-term safety is good, but careful follow-up is essential for pediatric patients requiring pacemakers.

Area of Science:

  • Pediatric Cardiology
  • Biomedical Engineering
  • Cardiac Electrophysiology

Background:

  • Epicardial pacing is often preferred for pediatric patients due to anatomical considerations.
  • Long-term safety data for epicardial pacemakers in children is crucial for clinical decision-making.

Purpose of the Study:

  • To assess the long-term safety and efficacy of epicardial pacemakers in a pediatric population.
  • To identify risk factors associated with reintervention in children with epicardial pacing.

Main Methods:

  • Retrospective review of 181 epicardial pacemakers and 260 electrodes implanted in 122 children between 1971 and 2001.
  • Analysis of patient data over a total follow-up of 789 patient-years.
  • Statistical analysis including univariate and multivariate risk factor identification for reintervention.

Main Results:

  • Reintervention was required in 75 patients (61.5%) after a median of 5.0 years, primarily due to battery depletion (60%) and electrode issues (36%).
  • Median sternotomy approach (RR 2.1, p=0.0256) and pacing indications other than atrioventricular block (RR 1.7, p=0.0314) were significant predictors of reintervention.
  • One death was attributed to pacemaker dysfunction; overall mortality was low.
  • Longevity of replacement pacemakers was comparable to initial implants.

Conclusions:

  • Epicardial pacing demonstrates reliability and acceptable long-term safety in children, with low morbidity and mortality.
  • A significant need for reintervention exists within five years, highlighting the importance of vigilant follow-up protocols.
  • Further research into optimizing lead and battery longevity may reduce reintervention rates.